236
A. Gibson et al
Special Report
nitrergic relaxations of mouse anococcygeus contracted by Tg
(Ayman et al., 2001). Thirdly, nitric oxide itself has been
found to inhibit, not activate, CCE in smooth muscle (Cohen
et al., 1999; Ayman et al., 2001). Thus, inhibition of CCE
represents an additional action of TRIM, independent of its
ability to inhibit nitric oxide synthase.
It is not yet possible to determine whether TRIM inhibits
CCE by a direct eect on the SOC or by interference with the
signal generated by depletion of the SR. There is mounting
evidence that SOCs may be comprised of protein subunits
similar to the transient receptor potential (TRP) proteins ®rst
detected in Drosophila. Several mammalian TRP homologues
have been identi®ed to date (Harteneck et al., 2000) raising
the possibility that the subunit composition and functional
characteristics of SOCs may vary widely among tissues. In
preliminary studies, using the polymerase chain reaction in
whole mouse anococcygeus, we have detected expression of
TRPs 1, 2, 3 and 6 (communicated to the Joint British/
Canadian Pharmacological Societies Meeting, Vancouver,
2001); more de®nitive studies using single smooth muscle
cells, freshly dispersed from the tissue, are now in progress.
Given this diversity of TRP proteins, it will be important to
determine whether the inhibitory action of TRIM reported
here is a general eect or whether it is tissue speci®c; if the
latter, then TRIM may prove an important tool for the
characterization of CCE in dierent cell types.
In conclusion, TRIM provides a novel, selective inhibitor
of CCE and should be useful in improving our understanding
of this ubiquitous calcium entry pathway. In addition, it may
act as a template for the development of analogues which are
both more potent and free from the complication of nitric
oxide synthase inhibition.
The authors thank the Wellcome Trust for support.
References
AYMAN, S., GIBSON, A., MCFADZEAN, I., REYNOLDS, M.
&
MERRITT, J.E., ARMSTRONG, W.P., BENHAM, C.D., HALLAM, T.J.,
JACOB, R., JAXA-CHAMIEC, A., LEIGH, B.K., MCCARTHY, S.E.,
MOORES, R. & RINK, T.J. (1990). SKF96365, a novel inhibitor of
receptor-mediated calcium entry. Biochem. J., 271, 515 ± 522.
WALLACE, P. (2001). Inhibition of capacitative calcium entry is
not obligatory for relaxation of the mouse anococcygeus by the
NO/cyclic GMP signalling pathway. Br. J. Pharmacol., 132,
807 ± 814.
MOORE, P.K.
& HANDY, R.L.C. (1997). Selective inhibitors of
BERRIDGE, M.J. (1995). Capacitative calcium entry. Biochem. J.,
312, 1 ± 11.
neuronal nitric oxide synthase - is no NOS really good NOS for
the nervous system? TiPS, 18, 204 ± 211.
CLEMENTI, E.
&
MELDOLESI, J. (1996). Pharmacological and
PAREKH, A.B. & PENNER, R. (1997). Store-depletion and calcium
in¯ux. Physiol. Rev., 77, 901 ± 930.
PUTNEY, J.W. (1990). Capacitative calcium entry revisited. Cell.
Calcium, 11, 611 ± 624.
PUTNEY, J.W. & MCKAY, R.R. (1999). Capacitative calcium entry
channels. BioEssays, 21, 38 ± 46.
functional properties of voltage-independent Ca2+ channels.
Cell. Calcium, 19, 269 ± 279.
COHEN, R.A., WEISBROD, R.M., GERICKE, M., YAGHOUBI, M.,
BIERL, C. & BOLOTINA, V. (1999). Mechanism of nitric oxide-
induced vasodilatation. Circ. Res., 84, 210 ± 219.
GIBSON, A., MCFADZEAN, I., TUCKER, J.F. & WAYMAN, C.P. (1994).
Variable potency of nitrergic-nitrovasodilator relaxations of the
mouse anococcygeus against dierent forms of induced tone. Br.
J. Pharmacol., 113, 1494 ± 1500.
GIBSON, A., MCFADZEAN, I., WALLACE, P. & WAYMAN, C.P. (1998).
Capacitative calcium entry and the regulation of smooth muscle
tone. TiPS, 19, 266 ± 269.
TEIXEIRA, C.E., BENTO, A.C., LOPES-MARTINS, S.A., TEIXEIRA, V.,
VON EICKESTEDT, M.N., MUSCARA, M.N., ARANTES, E.C.,
GIGLIO, J.R., ANTUNES, E. & DE NUCCI, G. (1998). Eects of
Tityus serrulatus scorpion venom on the rabbit isolated corpus
cavernosum and the involvement of NANC nitrergic nerve ®bres.
Br. J. Pharmacol., 123, 435 ± 442.
WALLACE, P., AYMAN, S., MCFADZEAN, I. & GIBSON, A. (1999).
Thapsigargin-induced tone and capacitative calcium in¯ux in
mouse anococcygeus smooth muscle. N.S. Arch. Pharmacol., 360,
368 ± 375.
GRYNKIEWICZ, G., POENIE, M.
& TSIEN, R.Y. (1985). A new
generation of Ca2+ indicators with greatly improved ¯uorescence
properties. J. Biol. Chem., 260, 3440 ± 3450.
HANDY, R.L.C., WALLACE, P., GAFFEN, Z., WHITEHEAD, K.J. &
MOORE, P.K. (1995). 1-(2-Tri¯uoromethylphenyl)imidazole
(TRIM): a potent inhibitor of neuronal nitric oxide synthase in
vitro is antinociceptive in the mouse. Br. J. Pharmacol., 116,
2349 ± 2350.
WAYMAN, C.P., MCFADZEAN, I., GIBSON, A. & TUCKER, J.F. (1996).
Two distinct membrane currents activated by cyclopiazonic acid-
induced calcium store depletion in single smooth muscle cells
from mouse anococcygeus. Br. J. Pharmacol., 117, 566 ± 572.
HARTENECK, C., PLANT, T.D. & SCHULTZ, G. (2000). From worm to
man: three subfamilies of TRP channels. TINS, 23, 159 ± 166.
(Received May 14, 2001
Revised June 29, 2001
Accepted July 10, 2001)
British Journal of Pharmacology vol 134 (2)